Optigenex Inc. Announces Supply And License Agreement With Suracell Inc. To Utilize The AC-11(R) Trademark And Technology For Or
October 21 2009 - 9:00AM
PR Newswire (US)
Company plans to market dietary supplements under the brand name
Suracell with AC-11(R) (Financial terms were not disclosed). NEW
YORK, Oct. 21 /PRNewswire-FirstCall/ -- Optigenex Inc. (Pinksheets:
OPGX) announced today the signing of a Supply and Trademark License
Agreement with Suracell Inc. to provide its patented ingredient
AC-11(R) for use in a focused nutritional and age management
dietary supplement program. The agreement coupled with Suracell's
marketing plans will provide another platform to introduce
Optigenex's technology under the registered trademark AC-11(R) to
health conscious consumers in the United States, Canada and South
Korea. Beginning in January 2010, Suracell will be marketing a
specific dietary supplement regimen. Participants will complete
lifestyle questionnaires and will be asked to provide specimens for
testing of key bio markers that will form the basis for a focused
nutritional supplement program utilizing the diverse line of
Suracell formulated products with AC-11(R). All-natural,
herbal-extracted and patented AC-11(R) is marketed by over 100
manufacturers and marketing companies in Japan, Europe, the Middle
East, the United States and Canada in a variety of anti-aging
cosmetic, dietary supplement and advanced DNA care products. Daniel
Zwiren, president and CEO of Optigenex Inc. said, "We are excited
to add Suracell to our family of customers. We believe Suracell's
scientifically validated formulas are an ideal fit for the unique
properties of AC-11(R), including natural DNA repair, immune
enhancement and inhibition of pro-inflammatory agents. The
licensing relationship we are entering into today will allow both
companies to expand significantly their respective businesses and
market penetration. A Suracell spokesperson added, "The addition of
AC -11(R) to the proprietary customized Suracell formulations gives
us a product line unparalleled in its potential benefits to its
customers. The evolving science surrounding AC 11(R) promises a
very exciting future for our product offerings. About Suracell
Inc.: Suracell Inc. provides personal genetic health programs
formulated to measure, assess treat and monitor the body's
individual genetic needs. The testing and analysis programs are
designed to pinpoint deficiencies and damage in an individual's DNA
and provide personalized recommended protocols consisting of
specially formulated nutraceuticals and positive lifestyle choices.
About Optigenex Inc.: Optigenex Inc. (http://www.optigenex.com/) is
a formulator, distributor and provider of proprietary next
generation skin care, supplements and bulk ingredient featuring
AC-11(R) (formerly known as C-MED-100(R)), a patented compound, as
its core technology. AC- 11(R) is the bioactive, water-soluble form
of the medicinal herb Uncaria tomentosa. For more information about
Optigenex please email the company at: . * The statements made in
this press release have not been evaluated by the Food and Drug
Administration. The products mentioned in this release are not
intended to diagnose, treat, cure or prevent any disease. CONTACT:
For more information about Optigenex please email the company at:
DATASOURCE: Optigenex Inc. CONTACT: For more information about
Optigenex please email the company at:
Copyright